XML 43 R34.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Discontinued Operations - Summary of Earnings (Loss) from Discontinued Operations (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Total Net Sales $ 93,824 $ 105,021  
Cost of products sold, excluding intangible asset amortization (28,441) (27,842)  
Related party cost of products sold, excluding intangible asset amortization 0 (97)  
Intangible asset amortization 0 (13,715)  
Research and development (6,654) (8,168)  
Selling, general and administrative (54,121) (60,995)  
Restructuring and other cost reduction initiatives (1,851) (3,802)  
Acquisition, integration, divestiture and related (6,373) (341)  
Other expense, net (344) (876)  
Interest expense, net [1] (5,294) (3,891)  
Loss from discontinued operations before income taxes (9,254) (14,706)  
Adjustment of spine disposal group to fair value 11,143 [2] 0 [2] $ (289,500)
Benefit for income taxes from discontinued operations 1,833 1,107  
Earnings (loss) from discontinued operations, net of tax 3,722 (13,599)  
Third Party Net [Member]      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Total Net Sales 93,824 104,918  
Related Party Net [Member]      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Total Net Sales $ 0 $ 103  
[1] A portion of the interest on our Term Loan (as defined and described in Note 8) has been allocated to discontinued operations consistent with the amount of proceeds used to repay a portion of the amounts outstanding under our Term Loan in accordance with our Credit Agreement (as defined and described in Note 8).
[2] We performed an impairment analysis of the spine segment in December 2023 on a held-for-sale basis. The fair value of consideration to be received upon closure of the transaction was less than the carrying value of the spine segment's net assets resulting in a write-down of $289.5 million. We updated our analysis as of March 31, 2024, which resulted in a reduction of the December 2023 write-down of $11.1 million.